Related Experiment Video
Updated: Aug 17, 2025

03:31
Author Spotlight: Enhancement of Salient Object Detection for Smart Grid Applications
Published on: December 15, 2023
604
[A lightweight multiscale target object detection network for melanoma based on attention mechanism manipulation]
Y Zhong1,2, W Che1,2, S Gao1,3
1Faculty of Information Engineering and Automation, Kunming University of Science and Technology, Kunming 650500, China.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University
|December 12, 2022
Summary
A new deep learning model, AM-YOLO, enhances melanoma detection accuracy by integrating coordinate and efficient attention mechanisms. This improved target detection model shows superior performance in identifying benign and malignant melanoma.
Area of Science:
- Deep learning
- Computer vision
- Medical imaging analysis
Context:
- Melanoma detection remains a critical challenge in dermatological diagnostics.
- Accurate and efficient identification of melanoma targets is essential for timely treatment.
- Existing target detection models may require further optimization for medical image analysis.
Purpose:
- To develop an advanced deep learning target detection model, AM-YOLO.
- To integrate coordinate attention and efficient channel attention mechanisms into the YOLOv5s architecture.
- To enhance the accuracy and efficiency of melanoma recognition.
Summary:
- The AM-YOLO model utilizes Mosaic and MixUp image enhancement techniques.
- It features a modified YOLOv5s backbone and neck network, incorporating coordinate and efficient channel attention mechanisms.
- Comparative experiments demonstrated superior performance of AM-YOLO over other YOLO variants in precision, recall, and mean average precision for melanoma detection.
Impact:
- AM-YOLO significantly improves melanoma recognition accuracy, achieving 92.8% mAP for benign and 87.1% mAP for malignant melanoma.
- The model exhibits a reduced model weight size, indicating improved efficiency.
- This deep learning approach shows promise for clinical application in melanoma target recognition.

